Applied Energetics (AERG) 10-Q 14 Nov 24 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2024	Nov. 13, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Period End Date	Sep. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Information [Line Items]
Entity Registrant Name	APPLIED ENERGETICS, INC.
Entity Central Index Key	0000879911
Entity File Number	001-14015
Entity Tax Identification Number	77-0262908
Entity Incorporation, State or Country Code	DE
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Contact Personnel [Line Items]
Entity Address, Address Line One	9070 S. Rita Road
Entity Address, Address Line Two	Suite 1500
Entity Address, City or Town	Tucson
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85747
Entity Phone Fax Numbers [Line Items]
City Area Code	(520)
Local Phone Number	628-7415
Entity Listings [Line Items]
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	AERG
Security Exchange Name	NONE
Entity Common Stock, Shares Outstanding		213,800,472

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 1,608,241	$ 1,319,526
Accounts receivable, net	190,443	567,792
Other assets	227,139	148,338
Total current assets	2,025,823	2,035,656
Long-term assets
Property and equipment - net	328,831	434,563
Right of use asset - operating	1,137,081	1,054,736
Security deposit	17,004	17,004
Total long-term assets	1,482,916	1,506,303
Total assets	3,508,739	3,541,959
Current liabilities
Accounts payable	351,350	312,958
Notes payable	94,651
Operating lease liability - current	250,021	166,927
Deferred Revenue	20,218	308,908
Accrued expenses	74,365	40,510
Accrued dividends	48,079	48,079
Total current liabilities	888,684	927,382
Long-term liabilities
Operating lease liability - non-current	1,018,506	994,491
Total long-term liabilities	1,018,506	994,491
Total liabilities	1,907,190	1,921,873
Stockholders’ Equity
Common stock, $.001 par value, 500,000,000 shares authorized; 213,760,508 and 211,236,688 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively	213,761	211,237
Additional paid-in capital	119,249,082	112,223,129
Accumulated deficit	(117,861,308)	(110,814,294)
Total stockholders’ equity	1,601,549	1,620,086
Total Liabilities and Stockholders’ Equity	3,508,739	3,541,959
Related Parties
Current liabilities
Due to related parties	50,000	50,000
Series A Convertible Preferred Stock
Stockholders’ Equity
Series A convertible preferred stock, $.001 par value, 2,000,000 shares authorized and 13,602 shares issued and outstanding at September 30, 2024 and December 31, 2023 (Liquidation preference $340,050 and $340,050, respectively)	$ 14	$ 14

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	213,760,508	211,236,688
Common stock, shares outstanding	213,760,508	211,236,688
Series A Convertible Preferred Stock
Series A convertible preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Series A convertible preferred stock, shares authorized	2,000,000	2,000,000
Series A convertible preferred stock, shares issued	13,602	13,602
Series A convertible preferred stock, shares outstanding	13,602	13,602
Series A convertible preferred stock, liquidation preference (in Dollars)	$ 340,050	$ 340,050

Condensed Consolidated Statemen

Condensed Consolidated Statements Of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Revenue	$ 747,720	$ 712,810	$ 1,662,598	$ 1,759,433
Cost of revenue	508,709	174,412	1,167,349	492,852
Gross profit	239,011	538,398	495,249	1,266,581
Operating expenses
General and administrative	2,457,321	2,219,641	7,117,731	6,401,550
Selling and marketing	86,398	94,092	238,174	297,447
Research and development	70,244	54,222	188,947	166,958
Total operating expenses	2,613,963	2,367,955	7,544,852	6,865,955
Operating loss	(2,374,952)	(1,829,557)	(7,049,603)	(5,599,374)
Other income/(expense)
Other income	267	20,287	2,589	35,769
Interest expense		(1,908)		(3,817)
Total other income/(expense)	267	18,379	2,589	31,952
Loss before provision for income taxes	(2,374,685)	(1,811,178)	(7,047,014)	(5,567,422)
Provision for income taxes
Net loss	(2,374,685)	(1,811,178)	(7,047,014)	(5,567,422)
Preferred stock dividends	(8,501)	(8,501)	(25,504)	(25,504)
Net loss attributable to common stockholders	$ (2,383,186)	$ (1,819,679)	$ (7,072,518)	$ (5,592,926)
Net loss attributable to common stockholders per common share - basic (in Dollars per share)	$ (0.01)	$ (0.01)	$ (0.03)	$ (0.03)
Net loss attributable to common stockholders per common share - diluted (in Dollars per share)	$ (0.01)	$ (0.01)	$ (0.03)	$ (0.03)
Weighted average number of common shares outstanding, basic (in Shares)	213,753,429	211,133,165	212,565,838	211,046,786
Weighted average number of common shares outstanding, diluted (in Shares)	213,753,429	211,133,165	212,565,838	211,046,786

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Changes in Stockholders’ (Deficit) Equity (Unaudited) - USD ($)	Preferred Stock	Common Stock	Additional Paid- In Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2022	$ 14	$ 210,843	$ 108,830,989	$ (103,463,863)	$ 5,577,983
Balance (in Shares) at Dec. 31, 2022	13,602	210,848,671
Stock-based compensation			758,187		758,187
RSU restricted stock		$ 10	21,075		21,085
RSU restricted stock (in Shares)		9,584
Common stock issued on exercise of options		$ 175	16,575		16,750
Common stock issued on exercise of options (in Shares)		175,000
Net loss				(1,938,020)	(1,938,020)
Balance at Mar. 31, 2023	$ 14	$ 211,034	109,626,819	(105,401,879)	4,435,988
Balance (in Shares) at Mar. 31, 2023	13,602	211,033,255
Balance at Dec. 31, 2022	$ 14	$ 210,843	108,830,989	(103,463,863)	5,577,983
Balance (in Shares) at Dec. 31, 2022	13,602	210,848,671
Net loss					(5,567,422)
Balance at Sep. 30, 2023	$ 14	$ 211,141	111,241,064	(109,031,285)	2,420,934
Balance (in Shares) at Sep. 30, 2023	13,602	211,146,688
Balance at Mar. 31, 2023	$ 14	$ 211,034	109,626,819	(105,401,879)	4,435,988
Balance (in Shares) at Mar. 31, 2023	13,602	211,033,255
Stock-based compensation			845,677		845,677
Net loss				(1,818,224)	(1,818,224)
Balance at Jun. 30, 2023	$ 14	$ 211,034	110,472,496	(107,220,103)	3,463,441
Balance (in Shares) at Jun. 30, 2023	13,602	211,033,255
Stock-based compensation			903,343		903,343
Common stock issued on exercise of options		$ 20	1,981		2,000
Common stock issued on exercise of options (in Shares)		20,000
Common stock issued for settlement of restricted stock units		$ 150	(150)
Common stock issued for settlement of restricted stock units (in Shares)		150,000
Common stock withheld to cover income tax withholding obligations		$ (57)	(136,614)		(136,671)
Common stock withheld to cover income tax withholding obligations (in Shares)		(56,567)
Net loss				(1,811,178)	(1,811,178)
Balance at Sep. 30, 2023	$ 14	$ 211,141	111,241,064	(109,031,285)	2,420,934
Balance (in Shares) at Sep. 30, 2023	13,602	211,146,688
Balance at Dec. 31, 2023	$ 14	$ 211,237	112,223,129	(110,814,294)	1,620,086
Balance (in Shares) at Dec. 31, 2023	13,602	211,236,688
Stock-based compensation			955,730		955,730
Common stock issued on exercise of options		$ 60	12,540		12,600
Common stock issued on exercise of options (in Shares)		60,000
Common stock issued on exercise of warrants		$ 66	3,894		3,960
Common stock issued on exercise of warrants (in Shares)		66,000
Common stock issued for settlement of restricted stock units		$ 12	(12)
Common stock issued for settlement of restricted stock units (in Shares)		11,666
Common stock withheld to cover income tax withholding obligations		$ (4)	(7,515)		(7,519)
Common stock withheld to cover income tax withholding obligations (in Shares)		(3,715)
Net loss				(2,611,379)	(2,611,379)
Balance at Mar. 31, 2024	$ 14	$ 211,371	113,187,766	(113,425,673)	(26,522)
Balance (in Shares) at Mar. 31, 2024	13,602	211,370,639
Balance at Dec. 31, 2023	$ 14	$ 211,237	112,223,129	(110,814,294)	$ 1,620,086
Balance (in Shares) at Dec. 31, 2023	13,602	211,236,688
Common stock issued on exercise of options (in Shares)					340,000
Net loss					$ (7,047,014)
Balance at Sep. 30, 2024	$ 14	$ 213,761	119,249,082	(117,861,308)	1,601,549
Balance (in Shares) at Sep. 30, 2024	13,602	213,760,508
Balance at Mar. 31, 2024	$ 14	$ 211,371	113,187,766	(113,425,673)	(26,522)
Balance (in Shares) at Mar. 31, 2024	13,602	211,370,639
Stock-based compensation			920,847		920,847
Issuance of common stock under the market offering		$ 1,896	4,169,705		4,171,601
Issuance of common stock under the market offering (in Shares)		1,896,182
Common stock issued on exercise of options		$ 280	60,720		61,000
Common stock issued on exercise of options (in Shares)		280,000
Common stock issued on exercise of warrants		$ 99	5,840		5,939
Common stock issued on exercise of warrants (in Shares)		99,000
Net loss				(2,060,950)	(2,060,950)
Balance at Jun. 30, 2024	$ 14	$ 213,646	118,344,878	(115,486,623)	3,071,915
Balance (in Shares) at Jun. 30, 2024	13,602	213,645,821
Stock-based compensation			979,099		979,099
Common stock issued for settlement of restricted stock units		$ 175	(175)
Common stock issued for settlement of restricted stock units (in Shares)		175,000
Common stock withheld to cover income tax withholding obligations		$ (60)	(74,720)		(74,780)
Common stock withheld to cover income tax withholding obligations (in Shares)		(60,313)
Net loss				(2,374,685)	(2,374,685)
Balance at Sep. 30, 2024	$ 14	$ 213,761	$ 119,249,082	$ (117,861,308)	$ 1,601,549
Balance (in Shares) at Sep. 30, 2024	13,602	213,760,508

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash Flows from Operating Activities
Net loss	$ (7,047,014)	$ (5,567,422)
Adjustments to reconcile net loss to net cash used in operating activities:
Noncash stock-based compensation expense	2,855,676	2,528,293
Amortization of ROU assets	152,192	97,245
Depreciation and amortization	161,167	90,564
Amortization of prepaid assets	167,035	153,366
Changes in assets and liabilities:
Accounts receivable	377,349	(50,902)
Prepaid and deposits	(56,534)	(254,479)
ROU liabilities	(127,428)	(77,286)
Deferred Revenue	(288,690)	366,006
Accounts payable	38,392	115,130
Accrued expenses and compensation	33,855	21,869
Net cash used in operating activities	(3,734,000)	(2,577,616)
Cash Flows from Investing Activities
Purchase of equipment	(55,435)	(177,904)
Net cash used in investing activities	(55,435)	(177,904)
Cash Flows from Financing Activities
Repayment on note payable	(94,651)	(503,694)
Proceeds from sale of common stock	4,171,601
Proceeds from note payable		155,541
Tax withholdings related to net share settlement of RSU’s	(82,299)	(136,671)
Proceeds from the exercise of stock option and warrants	83,499	18,750
Net cash provided by (used in) financing activities	4,078,150	(466,074)
Net change in cash and cash equivalents	288,715	(3,221,594)
Cash and cash equivalents, beginning of year	1,319,526	5,640,308
Cash and cash equivalents, at end of period	1,608,241	2,418,714
Supplemental disclosure of cash flow information
Cash paid for interest	4,941	3,817
Cash paid for taxes
Non-cash investing and financing activities
Insurance financing for prepaid insurance	189,302	155,541
Implementation of ASC 842	$ 234,537	$ 766,281

Organization of Business, Going

Organization of Business, Going Concern and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2024
Organization of Business, Going Concern and Summary of Significant Accounting Policies [Abstract]
ORGANIZATION OF BUSINESS, GOING CONCERN AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1 – ORGANIZATION OF BUSINESS, GOING CONCERN AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The unaudited condensed consolidated financial statements include the accounts of Applied Energetics, Inc. and its wholly owned subsidiary North Star Power Engineering, Inc. (“North Star”) (collectively, “company,” “Applied Energetics,” “we,” “our” or “us”). All intercompany balances and transactions have been eliminated. The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information, the instructions for Form 10-Q and the rules and regulations of the SEC. Accordingly, since they are interim statements, the accompanying unaudited condensed consolidated financial statements do not include all of the information and notes required by GAAP for annual financial statements, but reflect all adjustments consisting of normal, recurring adjustments, that are necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. Interim results are not necessarily indicative of the results that may be expected for any future periods. The December 31, 2023, balance sheet information was derived from the audited financial statements as of that date. The interim unaudited condensed consolidated financial statements should be read in conjunction with the company’s audited consolidated financial statements contained in our Annual Report on Form 10-K. Going Concern The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. For the nine months ended September 30, 2024, the company incurred a net loss of $7,047,014, had negative cash flows from operations of $3,734,000 and may incur additional future losses due to limited contract activity. At September 30, 2024, the company had total current assets of $2,025,823 and total current liabilities of $888,684, resulting in working capital surplus of $1,137,139. At September 30, 2024, the company had cash of $1,608,241. Based on the company’s current business plan, it believes its cash balance as of the date of this filing, together with anticipated revenues from government contracts, will be sufficient to meet its anticipated cash requirements for the near term. However, the company may be unable to achieve its current business plan. Such conditions raise substantial doubts about the company’s ability to continue as a going concern for one year from the date the financial statements are issued. The company’s existence depends upon management’s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing the business and raising capital as needed. These efforts may not result in profitable operations or overcome liquidity concerns. The accompanying condensed consolidated financial statements do not include any adjustments relating to the recoverability of assets, the amount or classification of liabilities or otherwise that might be necessary should the company be unable to continue as a going concern. Trade conditions, such as exacerbated supplier shutdowns and delays, contribute to this uncertainty. Additionally, Russia’s military action in Ukraine, war in the Middle East, and related economic sanctions around the globe, could impact the company’s ability to source necessary supplies and equipment which could materially and adversely affect its ability to continue as a going concern. In addition, the company’s ability to continue as a going concern may depend on its ability to raise capital, which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity. This may result in third-party financing being unavailable on terms acceptable to the company or at all. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. To further improve its liquidity position, the company’s management continues to explore additional equity financing through discussions with investment bankers and private investors. The company may be unsuccessful in its effort to secure additional equity financing. The financial statements do not include any adjustments relating to the recoverability of assets and the amount or classification of liabilities that might be necessary should the company be unable to continue as a going concern. Applied Energetics, Inc. is a corporation organized and existing under the laws of the State of Delaware. Our headquarters are located at 9070 S. Rita Road Suite 1500, Tucson, Arizona, 85747, including office and laboratory space, and our telephone number is (520) 628-7415. Use of Estimates The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Management bases its assumptions on historical experiences and on various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. In addition, management considers the basis and methodology used in developing and selecting these estimates, the trends in and amounts of these estimates, specific matters affecting the amount of and changes in these estimates, and any other matters related to these estimates, including significant issues concerning accounting principles and financial statement presentation. Such estimates and assumptions could change in the future as more information becomes known which could impact the amounts reported and disclosed herein. Significant estimates include revenue recognition, carrying amounts of long-lived assets, valuation assumptions for share-based payments, effective borrowing rate determinations, valuation and calculation of measurements of income tax assets and liabilities. Net Loss Attributable to Common Stockholders Basic loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period before giving effect to stock options, stock warrants, restricted stock units and convertible securities outstanding, which are considered to be dilutive common stock equivalents. Diluted net loss per common share is calculated based on the weighted average number of common and potentially dilutive shares outstanding during the period after giving effect to dilutive common stock equivalents. Contingently issuable shares are included in the computation of basic loss per share when issuance of the shares is no longer contingent. The number of shares underlying warrants, options, restricted stock units and our Series A Convertible Preferred Stock, which were not included in the computation of earnings per share because the effect was antidilutive, was 31,044,936 and 31,623,768 for the nine months ended September 30, 2024 and 2023, respectively. Significant Concentrations and Risks We maintain cash balances at a commercial bank, and, at times, balances exceed FDIC limits. As of September 30, 2024, $1,086,115 was uninsured.

New Accounting Standards

New Accounting Standards	9 Months Ended
	Sep. 30, 2024
New Accounting Standards [Abstract]
NEW ACCOUNTING STANDARDS	NOTE 2 – NEW ACCOUNTING STANDARDS The company has reviewed all issued accounting pronouncements. The company does not expect the adoption of any pronouncements to have an impact on its results of operations or financial position.

Notes Payable

Notes Payable	9 Months Ended
	Sep. 30, 2024
Notes Payable [Abstract]
NOTES PAYABLE	NOTE 3 – NOTES PAYABLE Premium Financing On March 12, 2024, the company entered into an agreement with Oakwood D&O Insurance to provide financing in the original principal amount of $189,302 for the insurance premium associated with two D&O policies. Both policies commenced March 12, 2024, and provided coverage for the next 15 months, expiring June 11, 2025. The loan bears interest at a fixed rate of 9.50% per annum, requires the company to prepay $41,057 and appears on the balance sheet as a current asset. On April 12, 2024, the company made the first of twelve-monthly principal and interest payments of $15,775 on the loan, the aggregate amount of principal and interest on which is $199,184. The last payment is scheduled to be made on March 12, 2025. As of September 30, 2024, the outstanding principal and interest balance on the note was $94,651 and was recorded as notes payable, a current liability, on the company’s unaudited condensed consolidated balance sheet. Notes Payable Reconciliation The following reconciles notes payable as of September 30, 2024, and December 31, 2023: September 30, December 31, Beginning balance $ - $ 400,000 Notes payable 189,302 155,541 Payments on notes payable (94,651 ) (555,541 ) Total 94,651 - Less-Notes payable – current 94,651 - Notes payable – non-current $ - $ - Future principal payments for the company’s notes payable as of September 30, 2024, are as follows: 2024, three months ended $ 47,326 2025 47,325 Thereafter - Total $ 94,651 The company’s note payable principal and interest balance of $94,651 is due within the next twelve months, in accordance with the terms of note payable.

Due to Related Parties

Due to Related Parties	9 Months Ended
	Sep. 30, 2024
Due to Related Parties [Abstract]
DUE TO RELATED PARTIES	NOTE 4 – DUE TO RELATED PARTIES It has come to the board’s attention that on July 31, 2018, our now deceased CEO deposited $50,000 into the company’s account. Although it has been suggested that the funds may have been intended for use toward Mr. Dearmin’s healthcare, the board does not know for certain what the purpose of the funds were or the nature of any intended investment. Accordingly, the board is investigating the appropriate disposition of the funds which will likely be to the estate of Mr. Dearmin. Until such a determination is made, the board does not intend to use these funds for any corporate purpose. For reporting purposes, the company has treated the deposit as a due to related party.

Stockholders_ Equity

Stockholders’ Equity	9 Months Ended
	Sep. 30, 2024
Stockholders’ Equity [Abstract]
STOCKHOLDERS’ EQUITY	NOTE 5 – STOCKHOLDERS’ EQUITY Authorized Capital Stock During the nine months ended September 30, 2023, the company issued 100,000 shares of common stock upon the exercise of options at an exercise price of $0.07 a share, for proceeds in the amount of $7,000. During the nine months ended September 30, 2023, the company issued 75,000 shares of common stock upon the exercise of options at an exercise price of $0.13 a share, for proceeds in the amount of $9,750. During the nine months ended September 30, 2023, the company issued 9,584 shares of common stock with a grant date fair value of $21,085, pursuant to a restricted stock agreement dated May 2021. During the nine months ended September 30, 2023, the company issued 10,000 shares of common stock upon the exercise of 10,000 options at an exercise price of $0.13 a share, for proceeds in the amount of $1,300. During the nine months ended September 30, 2023, the company issued 10,000 shares of common stock upon the exercise of 10,000 options at an exercise price of $0.07 a share During the nine months ended September 30, 2023, restricted stock units covering 150,000 shares of the company’s common stock vested. The company withheld 56,567 of these shares of common stock from the holders pursuant to their restricted stock unit agreements to cover its tax withholding obligation of $136,671. During the nine months ended September 30, 2024, the company completed the placement of 1,896,182 shares of its common stock, par value, $0.001 per share, in a private sale to individual purchasers at a price of $2.20 per share, for aggregate proceeds in the amount of $4,171,601 During the nine months ended September 30, 2024, the company issued 180,000 shares of common stock upon the exercise of options at an exercise price of $0.07 a share, for proceeds in the amount of $12,600. During the nine months ended September 30, 2024, the company issued 60,000 shares of common stock upon the exercise of options at an exercise price of $0.35 a share, for proceeds in the amount of $21,000. During the nine months ended September 30, 2024, the company issued 100,000 shares of common stock upon the exercise of options at an exercise price of $0.40 a share, for proceeds in the amount of $40,000. During the nine months ended September 30, 2024, the company issued 165,000 shares of common stock upon exercise of warrants at an exercise price of $ 0.06 per share for proceeds in the amount of $9,899. During the nine months ended September 30, 2024, restricted stock units covering 186,666 shares of the company’s common stock vested. The company issued 186,666 and withheld 64,028 shares of common stock from the holders pursuant to their restricted stock unit agreements to cover its tax withholding obligation of $82,299. Preferred Stock As of September 30, 2024, and December 31, 2023, there were 13,602 shares of Series A Redeemable Convertible Preferred Stock (the “Series A Preferred Stock”) issued and outstanding, respectively. The company has not paid the dividends commencing with the quarterly dividend due August 1, 2013. Dividend arrearages as of September 30, 2024, including previously accrued dividends of $48,079 included in our balance sheet total approximately $388,129. Our Board of Directors suspended the declaration of the dividend, commencing with the dividend payable as of February 1, 2015, since we did not have a surplus (as such term is defined in the Delaware general corporation Law) as of December 31, 2014, until such time as we have a surplus or net profits for a fiscal year. Our Series A Preferred Stock has a liquidation preference of $25.00 per Share. The Series A Preferred Stock bears dividends at the rate of 6.5% of the liquidation preference per share per annum, which accrues from the date of issuance, and is payable quarterly. Dividends may be paid in: (i) cash, (ii) shares of our common stock (valued for such purpose at 95% of the weighted average of the last sales prices of our common stock for each of the trading days in the ten trading day period ending on the third trading day prior to the applicable dividend payment date), provided that the issuance and/or resale of all such shares of our common stock are then covered by an effective registration statement and the company’s common stock is listed on a U.S. national securities exchange or the Nasdaq Stock Market at the time of issuance or (iii) any combination of the foregoing. If the company fails to make a dividend payment within five business days following a dividend payment date, the dividend rate shall immediately and automatically increase by 1% from 6.5% of the liquidation preference per offered share of Series A preferred stock to 7.5% of such liquidation preference. If a payment default shall occur on two consecutive dividend payment dates, the dividend rate shall immediately and automatically increase to 10% of the liquidation preference for as long as such payment default continues and shall immediately and automatically return to the Initial dividend rate at such time as the payment default is no longer continuing. Each share of Series A Preferred Stock is convertible at any time at the option of the holder into a number of shares of common stock equal to the liquidation preference (plus any unpaid dividends for periods prior to the dividend payment date immediately preceding the date of conversion by the holder) divided by the conversion price (initially $12.00 per share, subject to adjustment in the event of a stock dividend or split, reorganization, recapitalization or similar event). If the closing sale price of the common stock is greater than 140% of the conversion price on 20 out of 30 trading days, the company may redeem the Series A Preferred Stock in whole or in part at any time through October 31, 2010, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the shares to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, subject to certain conditions. In addition, beginning November 1, 2010, the company may redeem the Series A Preferred Stock in whole or in part, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the Series A Preferred Stock to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, under certain conditions. If a change of control occurs, each holder of shares of Series A Convertible Preferred Stock that are outstanding immediately prior to the change of control shall have the right to require the corporation to purchase, out of legally available funds, any outstanding shares of Series A Convertible Preferred Stock at the defined purchase price. The purchase price is defined as: per share of Preferred Stock, 101% of the liquidation preference thereof, plus all unpaid and accumulated dividends, if any, to the date of purchase thereof. The purchase price is payable, at the company’s option, (x) in cash, (y) in shares of the common stock at a discount of 5% from the fair market value of Common Stock on the Purchase Date (i.e. valued at a 95% discount of the Common Stock on the Purchase Date), or (z) any combination thereof. If the company pays all or a portion of the purchase price in Common Stock, no fractional shares of Common Stock will be issued; instead, the company will round the applicable number of shares of Common Stock up to the nearest whole number of shares; provided that the company may pay the Purchase Price (or a portion thereof), whether in cash or in shares of Common Stock, only if the company has funds legally available for such payment and may pay the Purchase Price (or a portion thereof) in shares of its Common Stock only if (i) the Common Stock is listed on a U.S. national securities exchange or the Nasdaq Stock Market at the time of issuance and (ii) a shelf registration statement covering the issuance by the company and/or resales of the Common Stock issuable as payment of the Purchase Price is effective on the Payment Date unless such shares are eligible for immediate resale in the public market by non-affiliates of the company. Share-Based Payments Effective November 12, 2018, the Board of Directors of Applied Energetics, Inc. adopted the 2018 Incentive Stock Plan. The plan provides for the allocation and issuance of stock, restricted stock purchase offers and options (both incentive stock options and non-qualified stock options) to officers, directors, employees and consultants of the company. The board reserved a total of 50,000,000 shares for possible issuance under the plan. The company has, from time to time, also granted non-plan options and restricted stock units to certain officers, directors, employees and consultants. Total stock-based compensation expense for grants to officers, employees and consultants was $2,855,676 and $2,528,293 for the nine months ended September 30, 2024, and 2023, respectively, which was charged to general and administrative expense. During the nine months ended September 30, 2024, the company issued non-qualified stock options to purchase up to 250,000 shares of common stock, at an exercise price of $1.99, to one director. These options vest over a period of three years in the amount of 100,000 shares on the first anniversary of their issuance and 75,000 shares on each of the second and third anniversaries. The $2,855,676 stock-based compensation for the nine months ended September 30, 2024, was comprised of $1,464,627 option expense and $1,391,049 expense from the vesting of the restricted stock units. The company recognized no related income tax benefit because our deferred tax assets are fully offset by a valuation allowance. As of September 30, 2024, the company has $7,902,394 of unrecognized compensation cost related to unvested stock options granted and outstanding, net of estimated forfeitures. The cost is expected to be recognized on a weighted average basis over a period of approximately six years. The following table summarizes the activity of our stock options for the nine months ended September 30, 2024: Shares Weighted Weighted Intrinsic Outstanding at December 31, 2023 26,195,434 $ 0.64 9.37 $ 226,821,848 Granted 250,000 1.99 9.52 1,881,267 Exercised (340,000 ) 0.22 4.91 1,597,030 Forfeited or expired - - - - Outstanding at September 30, 2024 26,105,434 0.66 5.30 227,106,085 Outstanding and exercisable at September 30, 2024 21,652,931 0.32 4.61 92,930,566 We determine the fair value of option grant share-based awards at their grant date, using a Black-Scholes- Merton Option- Pricing Model applying the assumptions in the following table: Nine months Ended 2024  2023 Assumptions: Risk-free interest rate 1.99% 1.26 – 3.98% Expected dividend yield 0% 0% Expected volatility 103.88% 109.48 – 111.62% Expected life (in years) 6.5 6.0 The fair value of restricted stock and restricted stock units was estimated using the closing price of our common stock on the date of award and fully recognized upon vesting. Restricted stock activity for the nine months ended September 30, 2024, was as follows: Restricted Stock Shares Weighted Nonvested at December 31, 2023 3,480,454 2.15 Granted – restricted stock units and awards - - Granted – performance-based stock units - - Canceled - - Vested (186,666 ) 2.33 Nonvested at September 30, 2024 3,293,788 2.27 As of September 30, 2024, and December 31, 2023, there was $3,790,535 and $5,181,584, respectively, in unrecognized stock- based compensation related to unvested restricted stock agreements, net of estimated forfeitures. Warrant stock activity for the nine months ended September 30, 2024, was as follows: Warrant Activity Weighted Weighted Shares Price (years) Outstanding at December 31, 2023 1,750,000 $ 0.06 5.53 Granted - - - Exercised (165,000 ) 0.06 4.78 Forfeited - - - Outstanding and exercisable at September 30, 2024 1,585,000 $ 0.06 4.78 Warrants Outstanding Warrants Exercisable Weighted Weighted Weighted Shares Contractual Avg. Shares Avg. Range of Exercise Prices Outstanding Years Price Exercisable Price $0.05 – $0.07 1,585,000 4.78 $ 0.0600 1,585,000 $ 0.0600 1,585,000 4.78 $ 0.0600 1,585,000 $ 0.0600

Revenue Recognition

Revenue Recognition	9 Months Ended
	Sep. 30, 2024
Revenue Recognition [Abstract]
REVENUE RECOGNITION	NOTE 6 – REVENUE RECOGNITION The company derives revenue from technical research detailing the findings of its investigations to its customers under contract for specific projects. Under Topic 606, revenue is recognized when control of promised goods and services is transferred to customers, and the amount of revenue recognized reflects the consideration to which an entity expects to be entitled in exchange for the goods and services transferred. A performance obligation is a contractual promise to transfer a distinct good or service to the customer and is the unit of account under Topic 606. The transaction price of a contract is allocated to distinct performance obligations and recognized as revenue when or as the performance obligations are satisfied. The company’s contracts require significant integrated services and are accounted for as a single performance obligation, and revenue is recognized by the company over the contract term at a fixed contract price. During the nine months ended September 30, 2024, the company modified its contract with a customer for changes in the contract specifications and requirements. The modification was for services that are not distinct from the existing contract due to the significant integration of services performed. The modification was accounted for as if it was part of the existing contract and a cumulative catch-up adjustment was recorded for the nine months ended September 30, 2024. Contract modifications are routine in the performance of our contracts. Contracts are often modified to account for changes in the contract specifications or requirements. In most instances, contract modifications are for goods or services that are not distinct, and, therefore, are accounted for as part of the existing contract. The following table summarizes the company’s accounts receivable, net, September 30, December 31, Accounts receivable $ 190,433 $ 153,029 Unbilled receivable - 414,763 Total $ 190,433 $ 567,792 Concentrations During the three months ended September 30, 2024, three customers accounted for a total of $747,720 in revenue or 100% of revenue recognized. During the nine months ended September 30, 2024, three customers accounted for a total of $1,650,096 in revenue or 99% of revenue recognized. As of September 30, 2024, the company has $190,433 or 100% of accounts receivable recorded as current assets on the balance sheet related to two customers. During the three months ended September 30, 2023, two customers accounted for a total of $712,810 in revenue or 100% of revenue recognized. During the nine months ended September 30, 2023, two customers accounted for a total of $1,679,836 in revenue or 95% of revenue recognized. As of December 31, 2023, the company has $567,792 or 100% of accounts receivable recorded as current assets on the balance sheet related to one customer.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 7 – COMMITMENTS AND CONTINGENCIES Operating Leases In March 2021, the company signed a five-year lease for a 13,000 square foot laboratory/office space in Tucson. The initial base rent was $6.7626 per rentable square foot for year one and escalated to $ 9.2009 per rentable square foot in year two, $11.4806 per rentable square foot in year three, and $13.1740 per rentable square foot in year four and is in addition to certain operating expenses and taxes. It is to escalate further to $14.9306 per rentable square foot in year five. On June 7, 2023, the company entered into an amendment to extend the term of the original lease from April 26, 2026 to July 31, 2028. Included in the lease amendment, commencing on August 1, 2023, is additional square footage in the amount of 9,805 rentable square feet (8,375 usable square feet). The initial base rent for this expansion space was $9.10 per rentable square foot for year one, which escalated to $10.20 in year two and is in addition to certain operating expenses and taxes. It is to escalate further to $11.30 in year three, $12.40 in year four and $13.50 in year five. On July 3, 2024, Applied Energetics, Inc. exercised its option to lease more than 5,000 square feet of additional space at the University of Arizona Tech Park. The company will occupy, in the aggregate, approximately 26,000 sq. ft. of space at the Arizona Tech Park. The company took the option to lease this additional space under the June 7, 2023, amendment. The company incurred lease expenses for its operating leases of $288,521 which was included in general and administrative expenses in the statements of operation for the period ended September 30, 2024. During the nine months ended September 30, 2024, the company made cash lease payments in the amount of $203,757. At September 30, 2024, the company had approximately $84,775 in future minimum lease payments due for the nine months ended. The below table presents the future minimum lease payments due reconciled to lease liabilities. Operating For the nine months ended September 30, 2024 2024, three months ended $ 84,775 2025 361,268 2026 394,256 2027 418,215 2028 250,317 Thereafter - Total undiscounted lease payments 1,508,831 Present value discount, less interest 240,304 Lease Liability $ 1,268,527 Guarantees The company agrees to indemnify its officers and directors for certain events or occurrences arising as a result of the officers or directors serving in such capacity. The maximum amount of future payments that the company could be required to make under these indemnification agreements is unlimited. However, the company maintains a director’s and officer’s liability insurance policy that limits its exposure and enables it to recover a portion of any future amounts paid. As a result, it believes the estimated fair value of these indemnification agreements is minimal because of its insurance coverage, and it has not recognized any liabilities for these agreements as of September 30, 2024 and 2023. Litigation On January 15, 2021, the company filed a complaint in the United States District Court, Southern District of New York, against Gusrae, Kaplan & Nusbaum and Ryan Whalen for malpractice and breach of New York Rules of Professional Conduct by both parties as former counsel to the company. On May 28, 2021, Gusrae, Kaplan & Nusbaum and Mr. Whalen filed a motion to dismiss the complaint. On June 25, 2021, the company filed an opposition to the motion. On July 13, 2021, Gusrae Kaplan & Nusbaum and Mr.Whalen filed their reply brief. On March 30, 2022, United States Magistrate Judge Debra Freeman signed an order denying the motion of GKN and Mr. Whalen to dismiss the company’s claim for malpractice and for rescission of the shares-for-fees agreement under which GKN and Whalen received 1,242,710 shares of the company’s common stock. The motion was partially granted as to the separate claim for violation of NYRPC 1.7 and 1.8 because the court found that it was duplicative of the malpractice claim. The parties completed discovery, and the court has approved a summary judgment briefing schedule proposed by the parties. The parties have each filed their motions for summary judgment. No trial date has been set. On July 26, 2023, the company filed a complaint in the Superior Court of the State of Delaware against Gusrae Kaplan Nusbaum PLLC and Ryan Whalen, for malicious prosecution of a federal securities fraud lawsuit which was filed by these defendants against the company and certain of its directors, attorneys and their law firms and an outside consultant, in July 2019 in the United States District Court for the Southern District of New York. The complaint filed by the company alleges that the claims by these defendants against it were frivolous and prosecuted for the improper purpose of hindering the company’s prosecution of a then pending case against George Farley, the company’s former CEO, which was later settled. The complaint further alleges that the defendants prosecuted their claim with malice causing the company damages valued in excess of $40 million. On September 11, 2023, Gusrae, Kaplan & Nusbaum and Mr. Whalen filed a motion to dismiss the complaint. On October 25, 2023, the company filed an opposition to the motion. The court heard oral argument on the motion on January 19, 2024, and took the motion under submission. On April 16, 2024, the court granted the motion on the grounds of lack of personal jurisdiction over the defendants. The company filed a Notice of Appeal with the Supreme Court of the State of Delaware on May 2, 2024. The company filed its Opening Brief on July 17, 2024. On October 8, 2024, the Clerk of the Delaware Supreme Court notified the parties that the court would hear oral arguments in the case on December 4, 2024, and that the hearing would be “ en banc As with any litigation, the company cannot predict the outcome with certainty, but the company expects to provide further updates on the status of the litigation as circumstances warrant. The company may, from time to time, be involved in legal proceedings arising from the normal course of business. Related Party In January 2023, the company made a $25,000 tax-deductible donation to Silicon Valley Defense Group (SVDG), a 501(c)(3) organization of which Christopher Donaghey, our Chief Financial and Operating Officer, is a founder and member of the Board of Directors. As its objective, SVDG “seeks to align and connect the people, capital, and ideas that will ensure allied democracies retain a durable techno-security advantage.”

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 8 – SUBSEQUENT EVENTS The company’s management has evaluated subsequent events occurring after September 30, 2024, the date of our most recent balance sheet, through the date our financial statements were issued. Subsequent to the nine months ended September 30, 2024, the company issued 40,000 shares of common stock upon exercise of warrants at an exercise price of $0.06 per share. Subsequent to the nine months ended September 30, 2024, the Company modified 2,800,000 outstanding options awarded to technical and administrative staff to reduce the exercise price from $2.35 per share to $0.81 per share. No executive team options were repriced.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (2,374,685)	$ (2,060,950)	$ (2,611,379)	$ (1,811,178)	$ (1,818,224)	$ (1,938,020)	$ (7,047,014)	$ (5,567,422)

Insider Trading Arrangements

Insider Trading Arrangements - shares		3 Months Ended
	Jun. 03, 2024	Sep. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted		false
Non-Rule 10b5-1 Arrangement Adopted		false
Rule 10b5-1 Arrangement Terminated		false
Non-Rule 10b5-1 Arrangement Terminated		false
Bradford T. Adamczyk [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		The Rule 10b5-1 Plan previously established by Bradford T. Adamczyk, our Executive Chairman, expired in accordance with its own terms as of July 15, 2024. Mr. Adamczyk has established a new Rule 10b5-1 Plan which is to take effect under its terms as of August 16, 2024, and is to continue in effect through October 14, 2025.
Name		Bradford T. Adamczyk
Title		Executive Chairman
Expiration Date		July 15, 2024
Adamczyk Family 2021 LLC [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		The Rule 10b5-1 Plan previously established by Adamczyk Family 2021 LLC, an entity controlled by Bradford T. Adamczyk, the company’s Executive Chairman, expired in accordance with its own terms as of July 15, 2024. The Adamczyk Family 2021 LLC has established a new Rule 10b5-1 Plan which is to take effect under its terms as of August 16, 2024, and is to continue in effect through October 14, 2025.
Name		Adamczyk Family 2021 LLC
Title		Executive Chairman
Expiration Date		July 15, 2024
Gregory J. Quarles [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		The Rule 10b5-1 Plan previously established by Gregory J. Quarles, the company’s President and Chief Executive Officer, expired in accordance with its own terms as of July 15, 2024. Dr. Quarles has established a new Rule 10b5-1 Plan which is to take effect under its terms as of August 16, 2024, and is to continue in effect through October 14, 2025.
Name		Gregory J. Quarles
Title		President and Chief Executive Officer
Expiration Date		July 15, 2024
Christopher Donaghey [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On June 3, 2024, Christopher Donaghey, Chief Operating and Financial Officer, adopted a written plan intended to satisfy the affirmative defense of Rule 10b5-1(c) that took effect on September 5, 2024, and is designed to be in effect until September 5, 2025 with respect to the sale of up to 770,000 shares of the company’s common stock all of which underlie stock options held by Mr. Donaghey. Through November 3, 2024, Mr. Donaghey has not sold any shares under the plan.
Name	Christopher Donaghey
Title	Chief Operating and Financial Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 5, 2024
Aggregate Available	770,000

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	9 Months Ended
	Sep. 30, 2024
Organization of Business, Going Concern and Summary of Significant Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The unaudited condensed consolidated financial statements include the accounts of Applied Energetics, Inc. and its wholly owned subsidiary North Star Power Engineering, Inc. (“North Star”) (collectively, “company,” “Applied Energetics,” “we,” “our” or “us”). All intercompany balances and transactions have been eliminated. The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information, the instructions for Form 10-Q and the rules and regulations of the SEC. Accordingly, since they are interim statements, the accompanying unaudited condensed consolidated financial statements do not include all of the information and notes required by GAAP for annual financial statements, but reflect all adjustments consisting of normal, recurring adjustments, that are necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. Interim results are not necessarily indicative of the results that may be expected for any future periods. The December 31, 2023, balance sheet information was derived from the audited financial statements as of that date. The interim unaudited condensed consolidated financial statements should be read in conjunction with the company’s audited consolidated financial statements contained in our Annual Report on Form 10-K.
Going Concern	Going Concern The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. For the nine months ended September 30, 2024, the company incurred a net loss of $7,047,014, had negative cash flows from operations of $3,734,000 and may incur additional future losses due to limited contract activity. At September 30, 2024, the company had total current assets of $2,025,823 and total current liabilities of $888,684, resulting in working capital surplus of $1,137,139. At September 30, 2024, the company had cash of $1,608,241. Based on the company’s current business plan, it believes its cash balance as of the date of this filing, together with anticipated revenues from government contracts, will be sufficient to meet its anticipated cash requirements for the near term. However, the company may be unable to achieve its current business plan. Such conditions raise substantial doubts about the company’s ability to continue as a going concern for one year from the date the financial statements are issued. The company’s existence depends upon management’s ability to develop profitable operations. Management is devoting substantially all of its efforts to developing the business and raising capital as needed. These efforts may not result in profitable operations or overcome liquidity concerns. The accompanying condensed consolidated financial statements do not include any adjustments relating to the recoverability of assets, the amount or classification of liabilities or otherwise that might be necessary should the company be unable to continue as a going concern. Trade conditions, such as exacerbated supplier shutdowns and delays, contribute to this uncertainty. Additionally, Russia’s military action in Ukraine, war in the Middle East, and related economic sanctions around the globe, could impact the company’s ability to source necessary supplies and equipment which could materially and adversely affect its ability to continue as a going concern. In addition, the company’s ability to continue as a going concern may depend on its ability to raise capital, which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity. This may result in third-party financing being unavailable on terms acceptable to the company or at all. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. To further improve its liquidity position, the company’s management continues to explore additional equity financing through discussions with investment bankers and private investors. The company may be unsuccessful in its effort to secure additional equity financing. The financial statements do not include any adjustments relating to the recoverability of assets and the amount or classification of liabilities that might be necessary should the company be unable to continue as a going concern. Applied Energetics, Inc. is a corporation organized and existing under the laws of the State of Delaware. Our headquarters are located at 9070 S. Rita Road Suite 1500, Tucson, Arizona, 85747, including office and laboratory space, and our telephone number is (520) 628-7415.
Use of Estimates	Use of Estimates The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Management bases its assumptions on historical experiences and on various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. In addition, management considers the basis and methodology used in developing and selecting these estimates, the trends in and amounts of these estimates, specific matters affecting the amount of and changes in these estimates, and any other matters related to these estimates, including significant issues concerning accounting principles and financial statement presentation. Such estimates and assumptions could change in the future as more information becomes known which could impact the amounts reported and disclosed herein. Significant estimates include revenue recognition, carrying amounts of long-lived assets, valuation assumptions for share-based payments, effective borrowing rate determinations, valuation and calculation of measurements of income tax assets and liabilities.
Net Loss Attributable to Common Stockholders	Net Loss Attributable to Common Stockholders Basic loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period before giving effect to stock options, stock warrants, restricted stock units and convertible securities outstanding, which are considered to be dilutive common stock equivalents. Diluted net loss per common share is calculated based on the weighted average number of common and potentially dilutive shares outstanding during the period after giving effect to dilutive common stock equivalents. Contingently issuable shares are included in the computation of basic loss per share when issuance of the shares is no longer contingent. The number of shares underlying warrants, options, restricted stock units and our Series A Convertible Preferred Stock, which were not included in the computation of earnings per share because the effect was antidilutive, was 31,044,936 and 31,623,768 for the nine months ended September 30, 2024 and 2023, respectively.
Significant Concentrations and Risks	Significant Concentrations and Risks We maintain cash balances at a commercial bank, and, at times, balances exceed FDIC limits. As of September 30, 2024, $1,086,115 was uninsured.

Notes Payable (Tables)

Notes Payable (Tables)	9 Months Ended
	Sep. 30, 2024
Notes Payable [Abstract]
Schedule of Reconciles Notes Payable	The following reconciles notes payable as of September 30, 2024, and December 31, 2023: September 30, December 31, Beginning balance $ - $ 400,000 Notes payable 189,302 155,541 Payments on notes payable (94,651 ) (555,541 ) Total 94,651 - Less-Notes payable – current 94,651 - Notes payable – non-current $ - $ -
Schedule of Future Principal Payments	Future principal payments for the company’s notes payable as of September 30, 2024, are as follows: 2024, three months ended $ 47,326 2025 47,325 Thereafter - Total $ 94,651

Stockholders_ Equity (Tables)

Stockholders’ Equity (Tables)	9 Months Ended
	Sep. 30, 2024
Stockholders’ Equity [Abstract]
Schedule of Stock Options Activity	The following table summarizes the activity of our stock options for the nine months ended September 30, 2024: Shares Weighted Weighted Intrinsic Outstanding at December 31, 2023 26,195,434 $ 0.64 9.37 $ 226,821,848 Granted 250,000 1.99 9.52 1,881,267 Exercised (340,000 ) 0.22 4.91 1,597,030 Forfeited or expired - - - - Outstanding at September 30, 2024 26,105,434 0.66 5.30 227,106,085 Outstanding and exercisable at September 30, 2024 21,652,931 0.32 4.61 92,930,566
Schedule of Black-Scholes- Merton Option-Pricing Model Applying the Assumptions	We determine the fair value of option grant share-based awards at their grant date, using a Black-Scholes- Merton Option- Pricing Model applying the assumptions in the following table: Nine months Ended 2024  2023 Assumptions: Risk-free interest rate 1.99% 1.26 – 3.98% Expected dividend yield 0% 0% Expected volatility 103.88% 109.48 – 111.62% Expected life (in years) 6.5 6.0
Schedule of Restricted Stock Activity	The fair value of restricted stock and restricted stock units was estimated using the closing price of our common stock on the date of award and fully recognized upon vesting. Restricted stock activity for the nine months ended September 30, 2024, was as follows: Restricted Stock Shares Weighted Nonvested at December 31, 2023 3,480,454 2.15 Granted – restricted stock units and awards - - Granted – performance-based stock units - - Canceled - - Vested (186,666 ) 2.33 Nonvested at September 30, 2024 3,293,788 2.27
Schedule of Warrant Stock Activity	Warrant stock activity for the nine months ended September 30, 2024, was as follows: Warrant Activity Weighted Weighted Shares Price (years) Outstanding at December 31, 2023 1,750,000 $ 0.06 5.53 Granted - - - Exercised (165,000 ) 0.06 4.78 Forfeited - - - Outstanding and exercisable at September 30, 2024 1,585,000 $ 0.06 4.78
Schedule of Range Exercise Prices of Warrants Outstanding and Exercisable	Warrants Outstanding Warrants Exercisable Weighted Weighted Weighted Shares Contractual Avg. Shares Avg. Range of Exercise Prices Outstanding Years Price Exercisable Price $0.05 – $0.07 1,585,000 4.78 $ 0.0600 1,585,000 $ 0.0600 1,585,000 4.78 $ 0.0600 1,585,000 $ 0.0600

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Sep. 30, 2024
Revenue Recognition [Abstract]
Schedule of Accounts Receivable, Net	The following table summarizes the company’s accounts receivable, net, September 30, December 31, Accounts receivable $ 190,433 $ 153,029 Unbilled receivable - 414,763 Total $ 190,433 $ 567,792

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies [Abstract]
Schedule of Future Minimum Lease Payments	The below table presents the future minimum lease payments due reconciled to lease liabilities. Operating For the nine months ended September 30, 2024 2024, three months ended $ 84,775 2025 361,268 2026 394,256 2027 418,215 2028 250,317 Thereafter - Total undiscounted lease payments 1,508,831 Present value discount, less interest 240,304 Lease Liability $ 1,268,527

Organization of Business, Goi_2

Organization of Business, Going Concern and Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Organization of Business, Going Concern and Summary of Significant Accounting Policies [Abstract]
Net loss	$ (2,374,685)	$ (2,060,950)	$ (2,611,379)	$ (1,811,178)	$ (1,818,224)	$ (1,938,020)	$ (7,047,014)	$ (5,567,422)
Cash flows from operations							(3,734,000)	$ (2,577,616)
Current assets	2,025,823						2,025,823		$ 2,035,656
Current liabilities	888,684						888,684		$ 927,382
Working capital surplus	1,137,139						1,137,139
Cash	1,608,241						$ 1,608,241
Antidilutive shares not included in the computation of earnings per share (in Shares)							31,044,936	31,623,768
Cash uninsured	$ 1,086,115						$ 1,086,115

Notes Payable (Details)

Notes Payable (Details) - USD ($)	Apr. 12, 2024	Mar. 12, 2024	Sep. 30, 2024	Dec. 31, 2023
Notes Payable [Line Items]
Bears interest rate		9.50%
Current asset		$ 41,057
Notes payable			$ 94,651
Oakwood D&O Insurance [Member]
Notes Payable [Line Items]
Original principal amount		$ 189,302
Expiring date		Jun. 11, 2025
Principal and interest payment	$ 15,775
Aggregate amount of principal and interest	$ 199,184
Notes payable			$ 94,651

Notes Payable (Details) - Sched

Notes Payable (Details) - Schedule of Reconciles Notes Payable - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Schedule of Reconciles Notes Payable [Abstract]
Beginning balance		$ 400,000	$ 400,000
Notes payable	189,302		155,541
Payments on notes payable	(94,651)	$ (503,694)	(555,541)
Total	94,651
Less-Notes payable – current	94,651
Notes payable – non-current

Notes Payable (Details) - Sch_2

Notes Payable (Details) - Schedule of Future Principal Payments - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Schedule of Future Principal Payments [Abstract]
2024, three months ended	$ 47,326
2025	47,325
Thereafter
Total	$ 94,651

Due to Related Parties (Details

Due to Related Parties (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023	Jul. 31, 2018
Related Party [Member]
Due to Related Parties [Line Items]
Due to related parties	$ 50,000	$ 50,000	$ 50,000

Stockholders_ Equity (Details)

Stockholders’ Equity (Details) - USD ($)			3 Months Ended					9 Months Ended
	Nov. 01, 2010	Oct. 31, 2010	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Stockholders’ Equity [Line Items]
Exercise price (in Dollars per share)								$ 0.22
Proceeds from issuance of common stock (in Dollars)								$ 4,171,601
Common stock exercise share								340,000
Common stock par value (in Dollars per share)			$ 0.001					$ 0.001		$ 0.001
Accrued dividends (in Dollars)								$ 48,079
Balance sheet total (in Dollars)								$ 388,129
Weighted average of the last sales prices								95%
Conversion price per share (in Dollars per share)			$ 12					$ 12
Conversion price percentage								140%
Discount at common stock from fair market value								95%
Share based compensation expenses (in Dollars)								$ 2,855,676	$ 2,528,293
Exercise price per share (in Dollars per share)								$ 1.99
Vesting period			3 years
Option expense (in Dollars)								$ 1,464,627
Restricted stock (in Dollars)								$ 1,391,049
Weighted average period								6 years
Minimum [Member]
Stockholders’ Equity [Line Items]
Dividend rate								1%
Maximum [Member]
Stockholders’ Equity [Line Items]
Dividend rate								6.50%
Options Three [Member]
Stockholders’ Equity [Line Items]
Issued shares of common stock			100,000					100,000
Exercise price (in Dollars per share)								$ 0.4
Common Stock [Member]
Stockholders’ Equity [Line Items]
Issued shares of common stock						100,000			100,000
Exercise price (in Dollars per share)									$ 0.07
Proceeds from issuance of common stock (in Dollars)									$ 7,000
Common stock exercise share				280,000	60,000	20,000	175,000
Withheld shares								64,028
Discount at common stock from fair market value								5%
Common Stock [Member] | Options [Member]
Stockholders’ Equity [Line Items]
Common stock exercise share								250,000
Options [Member]
Stockholders’ Equity [Line Items]
Issued shares of common stock			180,000			10,000		180,000	10,000
Exercise price (in Dollars per share)								$ 0.07	$ 0.13
Proceeds from issuance of common stock (in Dollars)								$ 12,600	$ 1,300
Common stock exercise share									10,000
Shares reserved for issuance			50,000,000					50,000,000
Options [Member] | Common Stock [Member]
Stockholders’ Equity [Line Items]
Issued shares of common stock						75,000			75,000
Exercise price (in Dollars per share)									$ 0.13
Proceeds from issuance of common stock (in Dollars)									$ 9,750
Restricted Stock [Member]
Stockholders’ Equity [Line Items]
Issued shares of common stock						9,584			9,584
Grant date fair value (in Dollars)									$ 21,085
Options Two [Member]
Stockholders’ Equity [Line Items]
Issued shares of common stock			60,000			10,000		60,000	10,000
Exercise price (in Dollars per share)								$ 0.35	$ 0.07
Proceeds from issuance of common stock (in Dollars)								$ 21,000	$ 700
Common stock exercise share									10,000
Restricted Stock Units (RSUs) [Member]
Stockholders’ Equity [Line Items]
Shares vested								186,666	150,000
Withheld shares								186,666	56,567
Tax withholding obligation (in Dollars)								$ 82,299	$ 136,671
Share based compensation expenses (in Dollars)								2,855,676
Options Three [Member]
Stockholders’ Equity [Line Items]
Proceeds from issuance of common stock (in Dollars)								$ 40,000
Options Four [Member]
Stockholders’ Equity [Line Items]
Issued shares of common stock			165,000					165,000
Exercise price (in Dollars per share)								$ 0.06
Proceeds from issuance of common stock (in Dollars)								$ 9,899
Options [Member] | Common Stock [Member]
Stockholders’ Equity [Line Items]
Shares of options vest			100,000					100,000
Second and Third Anniversaries [Member]
Stockholders’ Equity [Line Items]
Shares of options vest			75,000					75,000
Unvested Stock Options [Member]
Stockholders’ Equity [Line Items]
Unrecognized stock- based compensation (in Dollars)			$ 7,902,394					$ 7,902,394
Unvested Restricted Stock [Member]
Stockholders’ Equity [Line Items]
Unrecognized stock- based compensation (in Dollars)			$ 3,790,535					$ 3,790,535		$ 5,181,584
Series A Redeemable Convertible Preferred Stock [Member]
Stockholders’ Equity [Line Items]
Preferred stock, shares issued			13,602					13,602		13,602
Preferred stock, shares outstanding			13,602					13,602		13,602
Series A Preferred Stock [Member]
Stockholders’ Equity [Line Items]
Preferred stock, shares issued			13,602					13,602		13,602
Preferred stock, shares outstanding			13,602					13,602		13,602
Liquidation preference per share (in Dollars per share)			$ 25					$ 25
Series A preferred stock, dividend rate								6.50%
Liquidation preference, percentage	100%	100%						101%
Series A Preferred Stock [Member] | Minimum [Member]
Stockholders’ Equity [Line Items]
Preferred stock liquidation preference								7.50%
Series A Preferred Stock [Member] | Maximum [Member]
Stockholders’ Equity [Line Items]
Preferred stock liquidation preference								10%
Private Placement [Member] | Common Stock [Member]
Stockholders’ Equity [Line Items]
Issued shares of common stock			1,896,182					1,896,182
Exercise price (in Dollars per share)								$ 2.2
Proceeds from issuance of common stock (in Dollars)								$ 4,171,601
Common stock par value (in Dollars per share)			$ 0.001					$ 0.001

Stockholders_ Equity (Details)

Stockholders’ Equity (Details) - Schedule of Stock Options Activity - USD ($)		9 Months Ended
	Dec. 31, 2023	Sep. 30, 2024
Schedule of Stock Options Activity [Abstract]
Shares, Outstanding	26,195,434	26,105,434
Weighted Average Exercise Price, Outstanding	$ 0.64	$ 0.66
Weighted Average Contractual Term Outstanding, Outstanding	9 years 4 months 13 days	5 years 3 months 18 days
Intrinsic Value, Outstanding	$ 226,821,848	$ 227,106,085
Shares, Outstanding and exercisable		21,652,931
Weighted Average Exercise Price, Outstanding and exercisable		$ 0.32
Weighted Average Contractual Term, Outstanding and exercisable		4 years 7 months 9 days
Intrinsic Value, Outstanding and exercisable		$ 92,930,566
Shares, Granted		250,000
Weighted Average Exercise Price, Granted		$ 1.99
Weighted Average Contractual Term Outstanding, Granted		9 years 6 months 7 days
Intrinsic Value, Granted		$ 1,881,267
Shares, Exercised		(340,000)
Weighted Average Exercise Price, Exercised		$ 0.22
Weighted Average Contractual Term Outstanding, Exercised		4 years 10 months 28 days
Intrinsic Value, Exercised		$ 1,597,030
Shares, Forfeited or expired
Weighted Average Exercise Price, Forfeited or expired
Weighted Average Contractual Term Outstanding, Forfeited or expired
Intrinsic Value, Forfeited or expired

Stockholders_ Equity (Details_2

Stockholders’ Equity (Details) - Schedule of Black-Scholes- Merton Option-Pricing Model Applying the Assumptions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Schedule of Black-Scholes- Merton Option-Pricing Model Applying the Assumptions [Line Items]
Risk-free interest rate	1.99%
Expected dividend yield	0%	0%
Expected volatility	103.88%
Expected life (in years)	6 years 6 months	6 years
Minimum [Member]
Schedule of Black-Scholes- Merton Option-Pricing Model Applying the Assumptions [Line Items]
Risk-free interest rate		1.26%
Expected volatility		109.48%
Maximum [Member]
Schedule of Black-Scholes- Merton Option-Pricing Model Applying the Assumptions [Line Items]
Risk-free interest rate		3.98%
Expected volatility		111.62%

Stockholders_ Equity (Details_3

Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity - Restricted Stock [Member]	9 Months Ended
	Sep. 30, 2024 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares, Nonvested outstanding at beginning | shares	3,480,454
Weighted Average Fair Value per Share at Grant Date, Nonvested outstanding at beginning | $ / shares	$ 2.15
Shares, Canceled | shares
Weighted Average Fair Value per Share at Grant Date, Canceled | $ / shares
Shares, Vested | shares	(186,666)
Weighted Average Fair Value per Share at Grant Date, Vested | $ / shares	$ 2.33
Shares, Nonvested outstanding at ending | shares	3,293,788
Weighted Average Fair Value per Share at Grant Date, Nonvested outstanding at ending | $ / shares	$ 2.27
Restricted Stock Units and Awards [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares, Granted | shares
Weighted Average Fair Value per Share at Grant Date, Granted | $ / shares
Performance – Based Stock Units [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares, Granted | shares
Weighted Average Fair Value per Share at Grant Date, Granted | $ / shares

Stockholders_ Equity (Details_4

Stockholders’ Equity (Details) - Schedule of Warrant Stock Activity - Warrant [Member] - $ / shares		9 Months Ended
	Dec. 31, 2023	Sep. 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares, Outstanding	1,750,000	1,585,000
Weighted Average Exercise Price, Outstanding	$ 0.06	$ 0.06
Weighted Average Contractual Term (years), Outstanding	5 years 6 months 10 days	4 years 9 months 10 days
Shares, Granted
Weighted Average Exercise Price, Granted
Shares, Exercised		(165,000)
Weighted Average Exercise Price, Exercised		$ 0.06
Weighted Average Contractual Term (years), Exercised		4 years 9 months 10 days
Shares Forfeited
Weighted Average Exercise Price, Forfeited

Stockholders_ Equity (Details_5

Stockholders’ Equity (Details) - Schedule of Range Exercise Prices of Warrants Outstanding and Exercisable - Warrant [Member]	9 Months Ended
	Sep. 30, 2024 $ / shares shares
Schedule of Range Exercise Prices of Warrants Outstanding and Exercisable [Line Items]
Warrants Outstanding, Shares Outstanding (in Shares) | shares	1,585,000
Warrants Outstanding, Weighted Avg. Remaining Contractual Life in Years	4 years 9 months 10 days
Warrants Outstanding, Weighted Avg. Exercise Price	$ 0.06
Warrants Exercisable, Shares Exercisable (in Shares) | shares	1,585,000
Warrants Exercisable, Weighted Avg. Exercise Price	$ 0.06
$0.05 – $0.07 [Member]
Schedule of Range Exercise Prices of Warrants Outstanding and Exercisable [Line Items]
Warrants Outstanding, Range of Exercise Prices Lower Range Limit	0.05
Warrants Outstanding, Range of Exercise Prices Upper Range Limit	$ 0.07
Warrants Outstanding, Shares Outstanding (in Shares) | shares	1,585,000
Warrants Outstanding, Weighted Avg. Remaining Contractual Life in Years	4 years 9 months 10 days
Warrants Outstanding, Weighted Avg. Exercise Price	$ 0.06
Warrants Exercisable, Shares Exercisable (in Shares) | shares	1,585,000
Warrants Exercisable, Weighted Avg. Exercise Price	$ 0.06

Revenue Recognition (Details)

Revenue Recognition (Details) - USD ($)	3 Months Ended	9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Revenue Recognition [Line Items]
Accounts receivable	$ 190,443	$ 190,443		$ 567,792
Total revenue recognized	712,810		$ 1,679,836
Customer Concentration Risk [Member] | Customer [Member] | Revenue Benchmark [Member]
Revenue Recognition [Line Items]
Revenue recognized	$ 747,720	$ 1,650,096
Revenue recognized percentage	100%	99%
Customer Concentration Risk [Member] | Customer [Member] | Accounts Receivable [Member]
Revenue Recognition [Line Items]
Revenue recognized percentage		100%		100%
Accounts receivable	$ 190,433	$ 190,433		$ 567,792
Customer Concentration Risk [Member] | Two Customer [Member] | Revenue Benchmark [Member]
Revenue Recognition [Line Items]
Revenue recognized percentage	100%		95%

Revenue Recognition (Details) -

Revenue Recognition (Details) - Schedule of Accounts Receivable, Net - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Schedule of Accounts Receivable, Net [Abstract]
Accounts receivable	$ 190,433	$ 153,029
Unbilled receivable		414,763
Total	$ 190,433	$ 567,792

Commitments and Contingencies_2

Commitments and Contingencies (Details)			9 Months Ended
	Jul. 26, 2023 USD ($)	Jan. 31, 2023 USD ($)	Sep. 30, 2024 USD ($) shares	Jul. 03, 2024 m²	Dec. 31, 2023 shares	Aug. 01, 2023 m²	Jun. 07, 2023	Mar. 30, 2022 shares	Mar. 31, 2021 ft²
Commitments and Contingencies [Line Items]
Area of land | m²				26,000		8,375
Rentable square foot for year three							11.3		11.4806
Rentable square foot for year four							12.4		13.174
Rentable square foot for year five							13.5		14.9306
Lease expense (in Dollars)			$ 288,521
Cash lease payments amount (in Dollars)			203,757
Lease payments due for fiscal year (in Dollars)			$ 84,775
Common stock shares issued (in Shares) | shares			213,760,508		211,236,688
Excess of damages value (in Dollars)	$ 40,000,000
Silicon Valley Defense Group [Member]
Commitments and Contingencies [Line Items]
Tax deductible (in Dollars)		$ 25,000
University of Arizona Tech Park [Member]
Commitments and Contingencies [Line Items]
Area of land | m²				5,000
GKN and Whalen [Member]
Commitments and Contingencies [Line Items]
Common stock shares issued (in Shares) | shares								1,242,710
Laboratory/Office Space [Member]
Commitments and Contingencies [Line Items]
Area of land						9,805			13,000
Rentable square foot for year one							9.1		6.7626
Rentable square foot for year two							10.2		9.2009

Commitments and Contingencies_3

Commitments and Contingencies (Details) - Schedule of Future Minimum Lease Payments	Sep. 30, 2024 USD ($)
Schedule of Future Minimum Lease Payments [Abstract]
2024, three months ended	$ 84,775
2025	361,268
2026	394,256
2027	418,215
2028	250,317
Thereafter
Total undiscounted lease payments	1,508,831
Present value discount, less interest	240,304
Lease Liability	$ 1,268,527

Subsequent Events (Details)

Subsequent Events (Details) - $ / shares	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Subsequent Events [Line Items]
Warrants exercise price	$ 0.81
Outstanding options (in Shares)	26,105,434	26,195,434
Common Stock [Member]
Subsequent Events [Line Items]
Vested shares (in Shares)	40,000
Warrants exercise price	$ 2.35
Outstanding options (in Shares)	2,800,000
Common Stock [Member] | Warrant [Member]
Subsequent Events [Line Items]
Warrants exercise price	$ 0.06